On May 12th, the biaseparations.com website will be retired and migrated tosartorius.com.Learn moreabout our combined offering today!

Latest news

15Mar2023
Teknova and Sartorius BIA Separations Announce Collaboration to Address Critical Pain Point in Gene Therapy Process Development
2Feb2023
Sartorius BIA Separations and Arnav Biotech enter in collaboration to develop a mRNA synthesis and purification platform, supported with PATfix in-process analytical solution
22Nov2022
Sartorius BIA Separations and Exopharm sign joint research agreement to develop integrated technology for large-scale exosome production
25Oct2022
Downstream AAV Production: A Targeted Approach to improve Empty / Full capsid separation (a Case Study with Pharmaron)

Upcoming events

23Mar2023
25Mar2023
IGLD 2023
IGLD 2023
5Apr2023
Cell and Gene Therapy Insights
Cell and Gene Therapy Insights
18Apr2023
20Apr2023
mRNA Process Development & Manufacturing Europe
mRNA Process Development & Manufacturing Europe
27Jun2023
28Jun2023
3rd mRNA based Therapeutics Summit USA
3rd mRNA based Therapeutics Summit USA